🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Karim Fizazi

Université Paris-Saclay

ORCID: 0000-0002-6068-9474

Also affiliated with Centre Oscar Lambret

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial”.

Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial

The Lancet Oncology(2022)10.1016/s1470-2045(21)00757-9

N/A

4.9DataRank · unranked

188 citations

Howard I Scher, Shahneen Sandhu, Eleni Efstathiou, Primo N Lara, Evan Y Yu +90 more

Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial

Cancer Cell(2020)10.1016/j.ccell.2020.08.007

N/A

4.8DataRank · unranked

398 citations

Russell K. Pachynski, Vivek Narayan, Aude Fléchon, Gwénaëlle Gravis, Matthew D. Galsky +10 more

177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial

The Lancet(2024)10.1016/s0140-6736(24)01653-2

N/A

4.3DataRank · unranked

287 citations

Daniel Castellano, Ken Herrmann, Johann S. De Bono, Neal D. Shore, Kim N. +18 more

Final overall survival and safety analyses of the phase III PSMAfore trial of [177Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer

Annals of Oncology(2025)10.1016/j.annonc.2025.07.003

N/A

0.663DataRank · unranked

31 citations

K.N. Chi, Neal D. Shore, Ken Herrmann, Johann S. De Bono, Daniel Castellano +88 more

The Effect of Corticosteroids on Prostate Cancer Outcome Following Treatment with Enzalutamide: A Multivariate Analysis of the Phase III AFFIRM Trial

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1090

N/A

0.589DataRank · unranked

10 citations

Karim Fizazi, Fred Saad, Kim N. Chi, Mary-Ellen Taplin, Cora N. Sternberg +5 more

External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer

Journal of Clinical Oncology(2023)10.1200/jco.22.02661

N/A

0DataRank · unranked

29 citations

Qian Yang, Akash Roy, Bin Luo, John C. Araujo, Christopher J. Logothetis +15 more

Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004191

N/A

0DataRank · unranked

78 citations

Anne‐Gaëlle Goubet, Kousuke Ueda, Andrew Maltez Thomas, Valentin Quiniou, Cassandra Thélémaque +32 more

Comparison of Industry-Sponsored Trials (IST) and Investigator-Initiated Trials (IIT) in Advanced Genitourinary Cancers in the United States, Canada, United Kingdom and France

Clinical Genitourinary Cancer(2024)10.1016/j.clgc.2024.102210

N/A

0DataRank · unranked

1 citations

Jenny Peng, Di Jiang, Karim Fizazi, T. Powles, Nick James +2 more

1632P Impact of androgen pathway inhibitors on cognitive function in elderly patients with metastatic prostate cancer: Results from the COG-PRO trial

Annals of Oncology(2024)10.1016/j.annonc.2024.08.1713

N/A

0DataRank · unranked

0 citations

G. Baciarello, E. Meyer, François Christy, N. Allouache, Raffaele Ratta +12 more

Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis

The Lancet Oncology(2021)10.1016/s1470-2045(20)30730-0

N/A

0DataRank · unranked

112 citations

Ralph Jiang, David G. Wallington, Gavin Jones, Samuel R. Birer, Neil Jairath +20 more

Multivariable models of outcomes with [177Lu]Lu-PSMA-617: analysis of the phase 3 VISION trial

EClinicalMedicine(2024)10.1016/j.eclinm.2024.102862

N/A

0DataRank · unranked

26 citations

Andrei Gafita, Johann S. De Bono, Oliver Sartor, Kim N., Bernd J. Krause +11 more